Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6226
Lucid Diagnostics
LUCD
$114M
| $70.3K | ﹤0.01% |
65,743
+19,706
| +43% | +$21.2K |
2021 Q4
18 quarters
|
|
6227
Bain Capital GSS Investment Corp Warrants
BCSS.WS
| $69.8K | ﹤0.01% |
102,651
| – | – |
2025 Q4
2 quarters
|
|
|
NAKA
6228
Nakamoto Inc
NAKA
$148M
| $69.8K | ﹤0.01% |
17,664
+2,172
| +14% | +$14.5K |
2025 Q2
4 quarters
|
|
6229
Jerash Holdings
JRSH
$78.1M
| $69.3K | ﹤0.01% |
14,407
+14,405
| +720,250% | +$51K |
2023 Q4
10 quarters
|
|
6230
Minerva Neurosciences
NERV
$138M
| $69.1K | ﹤0.01% |
12,443
-11,889
| -49% | -$64.5K |
2014 Q3
47 quarters
|
|
6231
SMI 3Fourteen Full-Cycle Trend ETF
FCTE
$245M
| $69K | ﹤0.01% |
2,362
| – | – |
2024 Q3
7 quarters
|
|
6232
Tiziana Life Sciences
TLSA
$139M
| $68.7K | ﹤0.01% |
53,656
+1,500
| +3% | +$1.95K |
2020 Q2
24 quarters
|
|
6233
REX FANG & Innovation Equity Premium Income ETF
FEPI
$740M
| $68.6K | ﹤0.01% |
1,591
| – | – |
2024 Q2
8 quarters
|
|
6234
State Street Nuveen Municipal Bond ETF
MBND
$25.7M
| $68.4K | ﹤0.01% |
2,501
| – | – |
2025 Q1
5 quarters
|
|
6235
abrdn Bloomberg All Commodity Longer Dated Strategy K-1 Free ETF
BCD
$449M
| $68.4K | ﹤0.01% |
2,002
+2,000
| +100,000% | +$72.9K |
2023 Q2
12 quarters
|
|
6236
WisdomTree New Economy Real Estate Fund
WTRE
$14.6M
| $68.2K | ﹤0.01% |
2,724
| – | – |
2013 Q2
52 quarters
|
|
6237
AllianzIM U.S. Equity 6 Month Buffer10 Feb/Aug ETF
SIXF
$52.5M
| $68.1K | ﹤0.01% |
+2,000
| New | +$66.7K |
2026 Q2
0 quarters
|
|
6238
New Germany Fund
GF
$168M
| $67.2K | ﹤0.01% |
5,865
-97
| -2% | -$1.13K |
2013 Q4
50 quarters
|
|
|
FISN
6239
Deep Fission Inc
FISN
$246M
| $66.8K | ﹤0.01% |
+6,050
| New | +$69.6K |
2026 Q2
0 quarters
|
|
6240
ProShares Ultra Energy
DIG
$89.4M
| $66.5K | ﹤0.01% |
1,352
-1
| -0.1% | -$57 |
2023 Q4
10 quarters
|
|
6241
Jiayin Group
JFIN
$65.9M
| $66.3K | ﹤0.01% |
23,191
-25,397
| -52% | -$108K |
2020 Q3
23 quarters
|
|
6242
Kamada
KMDA
$452M
| $66.3K | ﹤0.01% |
9,033
-925
| -9% | -$7.3K |
2013 Q4
50 quarters
|
|
|
OPI
6243
Office Properties Income Trust
OPI
$335M
| $66.3K | ﹤0.01% |
+3,899
| New | +$67.4K |
2026 Q2
0 quarters
|
|
6244
Accuray
ARAY
$26.1M
| $66.3K | ﹤0.01% |
257,033
-31,780
| -11% | -$11.8K |
2013 Q2
52 quarters
|
|
6245
Amplify AI Powered Equity ETF
AIEQ
$115M
| $66K | ﹤0.01% |
1,335
-101
| -7% | -$4.85K |
2017 Q4
34 quarters
|
|
6246
Lite Strategy Inc
LITS
$37.1M
| $65.9K | ﹤0.01% |
71,408
+50
| +0.1% | +$52 |
2013 Q4
50 quarters
|
|
6247
iShares Currency Hedged MSCI ACWI ex US ETF
HAWX
$347M
| $65.9K | ﹤0.01% |
1,416
+1,415
| +141,500% | +$62.8K |
2026 Q1
1 quarter
|
|
6248
iShares Large Cap Deep Quarterly Laddered ETF
IVVB
$134M
| $65.8K | ﹤0.01% |
1,901
| – | – |
2025 Q4
2 quarters
|
|
6249
Global X Adaptive US Factor ETF
AUSF
$872M
| $65.8K | ﹤0.01% |
1,346
+1
| +0.1% | +$49 |
2025 Q2
4 quarters
|
|
6250
Pacer Swan SOS Conservative January ETF
PSCX
$47.3M
| $65.3K | ﹤0.01% |
+2,000
| New | +$64.2K |
2026 Q2
0 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.